ArticleLeukemia2003

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.

H Guven et al.PubMed ↗Publisher ↗

No numbers read from the abstract.